Education
About Us
Working with TipRanks
Follow Us
China Regenerative Medicine International Limited (HK:8158)
:8158
Total Valuation
China Regenerative Medicine International Limited has a market cap or net worth of HK$164.30M. The enterprise value is HK$206.61M.
Market CapHK$164.30M
Enterprise ValueHK$206.61M
Share Statistics
China Regenerative Medicine International Limited has 304,252,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding304,252,470
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China Regenerative Medicine International Limited’s return on equity (ROE) is 0.70 and return on invested capital (ROIC) is 21.66%.
Return on Equity (ROE)0.70
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)21.66%
Return on Capital Employed (ROCE)0.24
Revenue Per Employee2.67M
Profits Per Employee522.12K
Employee Count34
Asset Turnover0.67
Inventory Turnover139.67
Valuation Ratios
The current PE Ratio of China Regenerative Medicine International Limited is 29.7. China Regenerative Medicine International Limited’s PEG ratio is -0.04.
PE Ratio29.7
PS Ratio0.99
PB Ratio3.56
Price to Fair Value3.56
Price to FCF5.08
Price to Operating Cash Flow56.30
PEG Ratio-0.04
Income Statement
In the last 12 months, China Regenerative Medicine International Limited had revenue of 90.62M and earned 17.75M in profits. Earnings per share was 0.06.
Revenue90.62M
Gross Profit57.65M
Operating Income18.43M
Pretax Income17.75M
Net Income17.75M
EBITDA29.84M
Earnings Per Share (EPS)0.06
Cash Flow
In the last 12 months, operating cash flow was 2.98M and capital expenditures -627.00K, giving a free cash flow of 2.35M billion.
Operating Cash Flow2.98M
Free Cash Flow2.35M
Free Cash Flow per Share<0.01
Dividends & Yields
China Regenerative Medicine International Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.08
52-Week Price Change4.76%
50-Day Moving Average0.56
200-Day Moving Average0.53
Relative Strength Index (RSI)32.51
Average Volume (3m)55.39K
Important Dates
China Regenerative Medicine International Limited upcoming earnings date is Nov 12, 2025, TBA (Not Confirmed).
Last Earnings DateAug 22, 2025
Next Earnings DateNov 12, 2025
Ex-Dividend Date―
Financial Position
China Regenerative Medicine International Limited as a current ratio of 0.99, with Debt / Equity ratio of 261.66%
Current Ratio0.99
Quick Ratio0.99
Debt to Market Cap0.55
Net Debt to EBITDA1.04
Interest Coverage Ratio16.28
Taxes
In the past 12 months, China Regenerative Medicine International Limited has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
China Regenerative Medicine International Limited EV to EBITDA ratio is 4.05, with an EV/FCF ratio of 6.83.
EV to Sales1.33
EV to EBITDA4.05
EV to Free Cash Flow6.83
EV to Operating Cash Flow6.60
Balance Sheet
China Regenerative Medicine International Limited has HK$7.28M in cash and marketable securities with HK$76.05M in debt, giving a net cash position of -HK$68.77M billion.
Cash & Marketable SecuritiesHK$7.28M
Total DebtHK$76.05M
Net Cash-HK$68.77M
Net Cash Per Share-HK$0.23
Tangible Book Value Per ShareHK$0.08
Margins
Gross margin is 61.91%, with operating margin of 20.33%, and net profit margin of 19.59%.
Gross Margin61.91%
Operating Margin20.33%
Pretax Margin19.59%
Net Profit Margin19.59%
EBITDA Margin32.93%
EBIT Margin20.84%
Analyst Forecast
The average price target for China Regenerative Medicine International Limited is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―